Results 171 to 180 of about 26,841 (202)
Some of the next articles are maybe not open access.
[Rinsho ketsueki] The Japanese journal of clinical hematology, 2021
Helicobacter eradication therapy is the first-line therapy for patients with Helicobacter positive idiopathic thrombocytopenic purpura (ITP) in Japan. Indications for treatement in patients with Helicobacter negative, or post-Helicobacter eradicated ITP are platelet counts less than 20×106/l or severe bleeding.
openaire +1 more source
Helicobacter eradication therapy is the first-line therapy for patients with Helicobacter positive idiopathic thrombocytopenic purpura (ITP) in Japan. Indications for treatement in patients with Helicobacter negative, or post-Helicobacter eradicated ITP are platelet counts less than 20×106/l or severe bleeding.
openaire +1 more source
2017
Antiplatelet autoantibodies play a critical role in autoimmune thrombocytopenia (ITP). Thus, characterization of autoantigens recognized by autoantibodies is a prerequisite for elucidating its pathophysiology. Platelet glycoprotein (GP) IIb-IIIa and/or GPIb-IX are the two major autoantigens in ITP.
openaire +1 more source
Antiplatelet autoantibodies play a critical role in autoimmune thrombocytopenia (ITP). Thus, characterization of autoantigens recognized by autoantibodies is a prerequisite for elucidating its pathophysiology. Platelet glycoprotein (GP) IIb-IIIa and/or GPIb-IX are the two major autoantigens in ITP.
openaire +1 more source
Treatment of immune thrombocytopenia (ITP) secondary to malignancy: a systematic review
Platelets, 2022Gianmarco Podda +2 more
exaly
Ascorbate for the treatment of ITP
European Journal of Haematology, 1992van der Beek-Boter, J. W. +3 more
openaire +3 more sources